• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

BGI and Azerbaijan Thalassemia Center sign collaboration agreement

Bioengineer by Bioengineer
September 16, 2022
in Health
Reading Time: 3 mins read
0
BGI signs collaboration agreement in Azerbaijan
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

On 6th September 2022, the Azerbaijan Thalassemia Center and BGI held a virtual signing ceremony to seal a Collaboration Agreement. The partnership aims to improve thalassemia screening in Azerbaijan through genetic technology.

BGI signs collaboration agreement in Azerbaijan

Credit: BGI Genomics

On 6th September 2022, the Azerbaijan Thalassemia Center and BGI held a virtual signing ceremony to seal a Collaboration Agreement. The partnership aims to improve thalassemia screening in Azerbaijan through genetic technology.

In early 2021, in occasion of the “Prevention and Control of Global Haemoglobinopathies” announcement, BGI Poverty Prevention and Control Panel clearly stated they seek to export China’s advanced technologies for thalassemia to ‘Belt and Road Initiative’ countries, to jointly achieve comprehensive thalassemia control in the global community.

In April 2022, BGI’s wholly-owned subsidiary, Huada Biotechnology (Wuhan) Co., Ltd, obtained the medical device registration certificate from the National Drug Administration for its alpha and beta thalassemia gene detection kit (combining probe anchored polymerisation sequencing method).

This agreement was signed by Dr. Valeh Hüseynov, the Executive Director of National Hematology and Transfusiology Center, Dr. Agha Rza Aghayev, the supervisor of Azerbaijan’s medical genetics department, and Mr. Jeremy Cao, the Vice President of BGI IntDx. The two organizations have entered a strategic partnership and will work together for a thalassemia study research project in the country.

Dr Agha Rza Aghayev, Azerbaijan’s medical genetics department supervisor, had the following to say: “Thank you BGI for support and collaboration, I hope this research program will help us to build an effective and well-designed method for screening Thalassemia.”

“Azerbaijan is one of the countries with the highest prevalence rate of thalassemia,” said Zhiyu Peng, BGI Genomics vice president. “Our thalassemia gene detection testing combines cutting-edge high throughput sequencing platform and advantages of low cost and comprehensive detection. It helps scientific research partnership in methodology comparison, enhances new technology collaboration in the clinical testing and explore the screening of thalassemia in Azerbaijan. BGI also has a world hemoglobinopathy foundation focusing on fighting thalassemia worldwide, our goal is making the world a better place without this disease. BGI therefore proposes this agreement to reaffirm that we stand together with Azerbaijan’s thalassemia center and its people.”

Mr Jeremy Cao, the Vice President of BGI IntDx, said at the signing ceremony, “This is one of our pioneer overseas thalassemia projects and such agreement commits us to work together more closely towards common goals, the pursuit of screening and control of thalassemia, and the vision that in a not too distant future there will be a world without this disease. I would like to say I am confident that through our efforts and commitment, we will be able to achieve more and to continue to develop even stronger relationships and friendships between the people of Azerbaijan and BGI.”

Thalassemia, an inherited blood disorder, caused by the insufficient production of hemoglobin in the red blood cells that deliver oxygen and nutrients to all parts of the body. People with thalassemia have much less hemoglobin than normal people and usually suffer from mild to severe anemia.

The Azerbaijan Thalassemia Center is the main leading public medical institutions fighting thalassemia in the region. This Center not only provides service for patients who suffer from this disease but also for people with other genetic conditions. The country also offers a foundation providing medical services to foreign citizens at this Center.

About BGI Genomics

BGI Genomics, headquartered in Shenzhen China, is a pioneer providing thalassemia genetic testing services based on next-generation sequencing (NGS) technology since 2013. Expanding the availability of genetic testing has been instrumental in the screening, diagnosis and treatment of thalassemia. 



Share12Tweet8Share2ShareShareShare2

Related Posts

Detection of Invasive Mosquito Vector Species in UK Surveillance Traps Raises Public Health Concerns

October 1, 2025

Bariatric Surgery Enhances Short-Term Employment Prospects, Long-Term Benefits Remain Unclear

October 1, 2025

eGFR Shifts in Young Inpatients Undergoing Nutritional Rehab

October 1, 2025

Human-Specific Regulation Uncovered in Pre-Implantation Model

October 1, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    90 shares
    Share 36 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    63 shares
    Share 25 Tweet 16
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Ancient Squamate Reveals Mosaic Anatomy Insights

Pancreatic 68Ga-FAPI PET/CT Uptake Insights

Laparoscopic vs. Robotic Surgery for Complex Kidney Tumors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.